Susquehanna International Group’s Amicus Therapeutics FOLD Stock Holding History

Susquehanna International Group’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.55M	Buy	383,500 +10,600	+3%	+$152K	﹤0.01%	4055
2025 Q4	$5.31M	Sell	372,900 -59,500	-14%	-$585K	﹤0.01%	3922
2025 Q3	$3.41M	Buy	432,400 +421,300	+3,795%	+$3M	﹤0.01%	4733
2025 Q2	$63.6K	Sell	11,100 -8,600	-44%	-$55.5K	﹤0.01%	12034
2025 Q1	$161K	Sell	19,700 -74,500	-79%	-$689K	﹤0.01%	11163
2024 Q4	$887K	Buy	94,200 +22,600	+32%	+$235K	﹤0.01%	7267
2024 Q3	$765K	Buy	71,600 +31,800	+80%	+$346K	﹤0.01%	7440
2024 Q2	$395K	Sell	39,800 -104,700	-72%	-$1.07M	﹤0.01%	8830
2024 Q1	$1.7M	Sell	144,500 -45,900	-24%	-$587K	﹤0.01%	5706
2023 Q4	$2.7M	Buy	190,400 +158,000	+488%	+$1.79M	﹤0.01%	4755
2023 Q3	$394K	Sell	32,400 -6,700	-17%	-$86.4K	﹤0.01%	8770
2023 Q2	$491K	Buy	39,100 +5,300	+16%	+$62.9K	﹤0.01%	8362
2023 Q1	$375K	Sell	33,800 -115,000	-77%	-$1.42M	﹤0.01%	9228
2022 Q4	$1.82M	Sell	148,800 -38,200	-20%	-$430K	﹤0.01%	4892
2022 Q3	$1.95M	Buy	187,000 +80,300	+75%	+$895K	﹤0.01%	4975
2022 Q2	$1.15M	Buy	106,700 +35,700	+50%	+$294K	﹤0.01%	6195
2022 Q1	$672K	Sell	71,000 -39,200	-36%	-$368K	﹤0.01%	8186
2021 Q4	$1.27M	Buy	110,200 +72,700	+194%	+$810K	﹤0.01%	6630
2021 Q3	$358K	Sell	37,500 -54,500	-59%	-$557K	﹤0.01%	10190
2021 Q2	$887K	Sell	92,000 -113,400	-55%	-$1.11M	﹤0.01%	8093
2021 Q1	$2.03M	Sell	205,400 -23,700	-10%	-$367K	﹤0.01%	5876
2020 Q4	$5.29M	Buy	229,100 +84,900	+59%	+$1.74M	﹤0.01%	3332
2020 Q3	$2.04M	Sell	144,200 -59,700	-29%	-$870K	﹤0.01%	4585
2020 Q2	$3.08M	Buy	203,900 +133,400	+189%	+$1.63M	﹤0.01%	3756
2020 Q1	$651K	Sell	70,500 -24,900	-26%	-$237K	﹤0.01%	6365
2019 Q4	$929K	Sell	95,400 -900	-0.9%	-$8.24K	﹤0.01%	5663
2019 Q3	$772K	Sell	96,300 -36,100	-27%	-$392K	﹤0.01%	6283
2019 Q2	$1.65M	Sell	132,400 -662,300	-83%	-$8.4M	﹤0.01%	4556
2019 Q1	$10.8M	Buy	794,700 +538,100	+210%	+$6.57M	﹤0.01%	1669
2018 Q4	$2.46M	Sell	256,600 -161,700	-39%	-$1.78M	﹤0.01%	3221
2018 Q3	$5.06M	Sell	418,300 -749,400	-64%	-$10.5M	﹤0.01%	2690
2018 Q2	$18.2M	Sell	1,167,700 -932,700	-44%	-$14.1M	0.01%	1374
2018 Q1	$31.6M	Buy	2,100,400 +1,191,400	+131%	+$18.1M	0.01%	906
2017 Q4	$13.1M	Sell	909,000 -90,200	-9%	-$1.24M	﹤0.01%	1598
2017 Q3	$15.1M	Buy	999,200 +652,400	+188%	+$8.63M	0.01%	1441
2017 Q2	$3.49M	Buy	346,800 +161,800	+87%	+$1.3M	﹤0.01%	2908
2017 Q1	$1.32M	Sell	185,000 -131,500	-42%	-$831K	﹤0.01%	4550
2016 Q4	$1.57M	Sell	316,500 -235,600	-43%	-$1.63M	﹤0.01%	4575
2016 Q3	$4.09M	Buy	552,100 +274,600	+99%	+$1.85M	﹤0.01%	2485
2016 Q2	$1.51M	Sell	277,500 -966,200	-78%	-$6.76M	﹤0.01%	4070
2016 Q1	$10.5M	Buy	1,243,700 +687,000	+123%	+$4.87M	0.01%	1501
2015 Q4	$5.4M	Buy	556,700 +327,900	+143%	+$2.95M	﹤0.01%	2436
2015 Q3	$3.2M	Sell	228,800 -128,800	-36%	-$2.02M	﹤0.01%	3384
2015 Q2	$5.06M	Buy	357,600 +71,900	+25%	+$864K	﹤0.01%	2890
2015 Q1	$3.11M	Sell	285,700 -131,500	-32%	-$1.16M	﹤0.01%	3498
2014 Q4	$3.47M	Buy	417,200 +243,700	+140%	+$1.67M	﹤0.01%	3487
2014 Q3	$1.03M	Buy	173,500 +147,300	+562%	+$772K	﹤0.01%	5856
2014 Q2	$88K	Sell	26,200 -10,000	-28%	-$23.5K	﹤0.01%	9458
2014 Q1	$75K	Sell	36,200 -34,300	-49%	-$85.8K	﹤0.01%	8638
2013 Q4	$166K	Sell	70,500 -16,700	-19%	-$36.7K	﹤0.01%	8391
2013 Q3	$202K	Sell	87,200 -134,200	-61%	-$337K	﹤0.01%	7759
2013 Q2	$516K	Buy	+221,400	New	+$680K	﹤0.01%	5992

Other funds holding FOLD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Susquehanna International Group's FOLD Position: Q1 2026 in Review

Susquehanna International Group increased its Amicus Therapeutics (FOLD) stake by 3.2% in Q1 2026, buying an estimated $65.6K and bringing the position to 149,341 shares worth $2.16M. The position accounts for ﹤0.01% of the portfolio, ranked #5998.

Susquehanna International Group first reported a position in FOLD in Q3 2013 and has held it in 47 quarters since. The position peaked at $16.9M in Q1 2018. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

Susquehanna International Group held 149,341 shares of Amicus Therapeutics worth $2.16M as of Q1 2026.
Susquehanna International Group bought 4,578 Amicus Therapeutics shares in Q1 2026, an estimated $65.6K.
Amicus Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5998 holding.
Susquehanna International Group first reported a position in Amicus Therapeutics in Q3 2013 and has held it in 47 quarters since.
Susquehanna International Group's Amicus Therapeutics position peaked at $16.9M in Q1 2018.
298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.